Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Respir Med

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    August 2022
  1. OZSEZEN B, Yalcin E, Ademhan Tural D, Sunman B, et al
    Antimycobacterial prophylaxis regarding Bacillus Calmette-Guerin -associated complications in children with primary immunodeficiency.
    Respir Med. 2022;200:106919.
    PubMed     Abstract available

    November 2021
  2. LO CASCIO CM, Kaul V, Dhooria S, Agrawal A, et al
    Diagnosis of tuberculous pleural effusions: A review.
    Respir Med. 2021;188:106607.
    PubMed     Abstract available

    August 2021
  3. VIANA MACHADO F, Morais C, Santos S, Reis R, et al
    Evaluation of CD8(+) response in QuantiFERON-TB Gold Plus as a marker of recent infection.
    Respir Med. 2021;185:106508.
    PubMed     Abstract available

    May 2021
  4. MORGAN C, Barrett J, Brown A, Coughlan C, et al
    Respiratory samples to diagnose tuberculosis in the absence of chest x-ray abnormalities.
    Respir Med. 2021;185:106488.
    PubMed     Abstract available

    February 2021
  5. HAN DW, Jo KW, Kim OH, Shim TS, et al
    Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease.
    Respir Med. 2021;179:106340.
    PubMed     Abstract available

    December 2020
  6. TORRE A, Aliberti S, Castellotti PF, Cirillo DM, et al
    Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy.
    Respir Med. 2020;175:106204.
    PubMed     Abstract available

    September 2020
  7. WILSON M, O'Connor B, Matigian N, Eather G, et al
    Management of isoniazid-monoresistant tuberculosis (Hr-TB) in Queensland, Australia: a retrospective case series.
    Respir Med. 2020;173:106163.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.